Adicon Company

Established in 2004, Adicon operates 20 fully-owned diagnostic laboratories in China, offering diagnostic testing outsourcing services to more than 10,000 active customers, including hospitals, clinics and contract research organizations (CROs) in 28 provinces. China’s ICL industry is a fast-growing market, driven by growing healthcare expenditure, rising diagnostic demand, continued technology innovation and hospital cost control trends. As an ICL industry pioneer, Adicon has developed a scalable operation with high quality standards and a network of laboratories certified with China National Accreditation Services for Conformity Assessment (CNAS). Adicon’s comprehensive test portfolio includes a range of esoteric tests, addressing diverse customer demands.

Funding Status: Private Equity
Industry: Biotechnology, Health Care, Information Technology, Medical
Last Funding Date: 43388
Technology: Other
Founded Date: 1-8
Headquarters: China
Last Funding Type: Private Equity
Employee Number: 1001-5000